Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
246. |
ECCT/20/12/03 | CALINA STUDY A multicenter, open-label, single-arm study to evaluate the PK, safety, tolerability and efficacy of a new artemether-lumefantrine (2.5 mg:30 mg) dispersible tablet in the treatment of infants and neonates <5 kg body weight with acute uncomplicated Plasmodium falciparum malaria. Study number: CCOA566B2307 |
Principal Investigator(s) 1. Benhards Ragama Ogutu Site(s) in Kenya KEMRI-Centre for Clinical Research (CCR) |
View |
247. |
ECCT/15/10/02 | A non-randomized, open label, single dose, pharmacokinetics, safety and tolerability study of Captopril 50mgs in healthy Kenyan Adults. |
Principal Investigator(s) 1. Bernhards Ragama Ogutu Site(s) in Kenya KEMRI centre for clinical Research |
View |
248. |
ECCT/21/03/03 | PrEP My Way A Novel PrEP Delivery System to Meet the Needs of Young African Women |
Principal Investigator(s) 1. Prof. Elizabet Ann Bukusi Site(s) in Kenya Kisumu |
View |
249. |
ECCT/21/06/02 | VAT00008 A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older. |
Principal Investigator(s) 1. Videlis Nduba Site(s) in Kenya 1. Kenya Medical Research Institute (Nairobi City county) 2. KEMRI/Walter Reed Project Research Center-Kericho (Kericho county) 3. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center-Kisumu (Kisumu county) 4. Ganjoni Clinic – Mombasa (Mombasa county) 5. KEMRI/CCR Partners in Health R&D (PHRD)-Thika (Kiambu county) 6. Kenya Medical Research Institute (Kisumu county) 7. Moi University Clinical Research Centre (Uasin Gishu county) 8. Aga Khan University Hospital-Nairobi (Nairobi City county) 9. KEMRI CCR-Butere County Hospital Site- Butere (Kakamega county) |
View |
250. |
ECCT/21/06/10 | VAT00008 A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older |
Principal Investigator(s) 1. Kishorchandra Narsinh Mandaliya Site(s) in Kenya 1. Kenya Medical Research Institute (Kisumu county) 2. KEMRI/Walter Reed Project Research Center (Kericho county) 3. KEMRI/CCR Partners in Health R&D (PHRD) (Nairobi City county) 4. KEMRI CMR (Kisumu county) 5. Kenya Medical Research Institute (Nairobi City county) 6. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county) 7. Moi University Clinical Research Centre (Uasin Gishu county) 8. Aga Khan University Hospital (Nairobi City county) 9. KEMRI CCR-Butere County Hospital Site (Kakamega county) 10. Ganjoni Clinic (Mombasa county) |
View |